FDA-Authorized Eye-Tracking Technology
EarliPoint Evaluation is an FDA-authorized technology designed to help clinicians identify key social-communication markers associated with autism spectrum disorder in children up to age 8. It uses advanced eye-tracking and interactive visual assessments to measure how children engage with social information and their environment, providing objective insight alongside traditional evaluation methods.
- A more modern, data-informed assessment process
- Objective markers that support clinical decision-making
- Earlier access to answers and intervention
- Clearer understanding of developmental strengths and challenges

